β³ Fetching live dividend data...
Home βΊ Calculator βΊ AKYA Dividend Calculator 2026
Akoya Biosciences, Inc. Β· NASDAQ
Price: $1.29 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in AKYA β $5.77M in 10 years Β· $17,241.35/month
Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa. Their core product lineup features the PhenoCycler instrument, a compact benchtop fluidics system designed to integrate seamlessly with a microscope for automated image acquisition. Complementing this is the PhenoImager platform, which empowers researchers to intricately visualize, analyze, quantify, and characterize cells directly within diverse tissue samplesβsuch as fresh frozen or FFPE sections and tissue microarraysβthrough an efficient, automated, and high-throughput process. Akoya also supplies the essential reagents for these PhenoCycler and PhenoImager systems, alongside providing specialized biopharmaceutical services. Beyond hardware, Akoya offers a robust suite of software tools. Proxima serves as a cloud-based platform for the secure storage, comprehensive analysis, and collaborative sharing of spatial data. For image interpretation, the inForm Tissue software delivers automated analysis to precisely visualize and quantify biomarkers within tissue sections. Further streamlining data workflows, Phenoptr facilitates the consolidation and in-depth analysis of output tables generated by inForm. Finally, phenoptrReports is a user-friendly software application that generates intuitive reports and visualizations from phenoptr output, presented via an easy-to-navigate graphical user interface. Established in 2015, Akoya Biosciences maintains its corporate headquarters in Marlborough, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open AKYA position with:
Real after-tax yield depends on where you live and how you hold AKYA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 155.04% | 152.24% | $15,504 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 131.78% | 128.98% | $13,178 / yr |
| πΊπΈ US Taxable (20%) | 20% | 124.03% | 121.23% | $12,403 / yr |
| π¬π§ UK ISA | 0% | 155.04% | 152.24% | $15,504 / yr |
| π¬π§ UK Taxable | 8.75% | 141.47% | 138.67% | $14,147 / yr |
| π¨π¦ TFSA | 0% | 155.04% | 152.24% | $15,504 / yr |
| π¨π¦ CA Taxable | 25% | 116.28% | 113.48% | $11,628 / yr |
| π¦πΊ Super (pension) | 15% | 131.78% | 128.98% | $13,178 / yr |
| π¦πΊ AU Taxable | 30% | 108.53% | 105.73% | $10,853 / yr |
| π©πͺ DE Taxable | 26.375% | 114.15% | 111.35% | $11,415 / yr |
| π«π· FR Taxable | 30% | 108.53% | 105.73% | $10,853 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
AKYA pays quarterly β 4 times per year. Next ex-div: TBD.
How AKYA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AKYA sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| J-Other | 2025-07-08 | 56,322 | $5.70 | $321.0K | ||
| J-Other | 2025-07-08 | 50,000 | $2.01 | $100.5K | ||
| J-Other | 2025-07-08 | 44,959 | $2.68 | $120.5K | ||
| J-Other | 2025-07-08 | 35,562 | $19.94 | $709.1K | ||
| J-Other | 2025-07-08 | 30,549 | $11.24 | $343.4K | ||
| J-Other | 2025-07-08 | 28,500 | $0.38 | $10.8K | ||
| J-Other | 2025-07-08 | 62,566 | β | β | ||
| F-InKind | 2025-07-08 | 42,148 | β | β | ||
| J-Other | 2025-07-08 | 151,930 | $0.38 | $57.7K | ||
| J-Other | 2025-07-08 | 130,625 | $0.38 | $49.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AKYA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Akoya Biosciences, Inc. (AKYA) is currently trading at $1.29, 94% below its 52-week high. The current dividend yield is 155.04% based on an annual payout of $2.00 per share.
Akoya Biosciences, Inc. (AKYA) is a healthcare stock currently trading at $1.29 with a dividend yield of 155.04%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β